Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (CAPTAIN)--A Multicenter, Prospective, Randomized Trial

NCT06696820 is registered in ClinicalTrials.gov with Xiang Luo as lead sponsor.

NCT NCT06696820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06696820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (CAPTAIN)--A Multicenter, Prospective, Randomized Trial
Lead sponsor
Xiang Luo
Phase
Phase 2/3
Overall status
Completed
Start date
November 29, 2024
Completion date
June 3, 2026
Enrollment
429 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke